MIRA
INFORM REPORT
|
Report Date : |
11.01.2007 |
IDENTIFICATION DETAILS
|
Name : |
S ZHAVERI PHARMAKEM
PRIVATE LIMITED |
|
|
|
|
Formerly Known As : |
S ZHAVERI AND COMPANY |
|
|
|
|
Registered Office : |
109, Shiv Smruti
Chambers, 49, Dr. Annie Basent Road, Worli, Mumbai – 400018, India |
|
|
|
|
Country : |
India |
|
|
|
|
Financials
(as on) : |
31.03.2005 |
|
|
|
|
Date of Incorporation : |
06.06.2005 |
|
|
|
|
Com.
Reg. No.: |
11-153790 |
|
|
|
|
Com. Reg. No.: |
U51397MH2005PTC153790 |
|
|
|
|
TAN No.: (Tax Deduction & Collection
Account No.) |
MUMS48413B |
|
|
|
|
Legal Form : |
Private Limited
Liability Company |
|
|
|
|
Line of Business : |
The concern act as
indenting house engaged in marketing of pharmaceutical raw materials from
foreign manufacturers to multinational/ Indian Pharma/ Chemical factories |
RATING
& COMMENTS
|
MIRA’s Rating : |
Ba |
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered
normal. Capable to meet normal commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD5000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well
established concern in its field. Partners are reported as experienced,
respectable and having satisfactory means of their own. Their trade relations
are fair. Payments are usually correct and as per commitments. The concern can be
considered normal for business dealings at usual trade terms and conditions. Management assured
to provide more details soon. |
LOCATIONS
|
Registered / Head Office : |
109, Shiv Smruti
Chambers, 49, Dr. Annie Basent Road, Worli, Mumbai – 400018, India |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Research Centre : |
D-28 / 16, T. T. C.
Industrial Area, M. I. D. C., Turbhe, New Mumbai – 400075 |
|
Tel. No.: |
91-22-66607756 / 57 |
|
Fax No.: |
91-22-66607758 |
|
E-Mail : |
|
|
Website : |
|
|
Area
: |
700 Sq. ft. |
|
Status
: |
Owned |
|
|
|
|
Warehouse: |
32, Kewal
Industrial Estate, S.B.Marg, Lower Parel, Mumbai 400 018, India |
|
Area
: |
400 Sq.ft. |
|
Status
: |
Rented |
|
|
|
|
Branches : |
236, Kewal
Industrial Estate, S.B.Marg, Lower Parel, Mumbai 400 018, India |
|
Area
: |
1000 Sq.ft. |
|
Status
: |
Rented |
|
|
|
|
Administration Office: |
45, Tardeo Air
Condition Market, Mumbai 400 018, India |
DIRECTORS
|
Name : |
Mr. Vinodchandra B.
Seth |
|
Designation : |
Director |
|
Qualification : |
B.Sc Chemistry |
|
|
|
|
Name : |
Mrs. Nalini V. Seth |
|
Designation : |
Director |
|
|
|
|
Name : |
Mrs. Uma R. Jhaveri |
|
Designation : |
Director |
|
Qualification : |
B.Com |
|
|
|
|
Name : |
Mrs. Saloni Rajen
Jhaveri |
|
Designation : |
Director |
|
|
|
|
Name : |
Ms. Suhagi Rajen
Jhaveri |
|
Designation : |
Director |
KEY
EXECUTIVES
|
Name : |
Mr. Vinod B.Seth |
|
Designation : |
Partner |
|
Age : |
78 Years |
|
Qualification : |
B.Sc. Chemistry |
|
Experience : |
54 Years |
|
Previous Employment: |
Self Employed |
BUSINESS
DETAILS
|
Line of Business : |
The concern act as
indenting house engaged in marketing of pharmaceutical raw materials from
foreign manufacturers to multinational/ Indian Pharma/ Chemical factories |
|
|
|
|
Agencies Held: |
|
|
|
|
|
Imports from : |
Germany, USA, U.K.,
Europe, China and Japan |
|
|
|
|
Terms : |
|
|
Purchasing
: |
D/A or D/P |
GENERAL
INFORMATION
|
Suppliers : |
|
|
|
|
|
Customers : |
Manufacturer and
Actual Users |
|
|
|
|
No. of Employees : |
20 |
|
|
|
|
Bankers : |
Grindlays Bank, 90,
M.G.Road, Fort, Mumbai-400 001, India |
|
|
|
|
|
|
CAPITAL
STRUCTURE
Authorised Capital
:
|
No. of Shares |
Type |
Value |
Amount |
|
50,000 |
Equity Shares |
Rs.
10/- |
Rs.
0.500 Millions |
Issued, Subscribed & Paid-up
Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
50,000 |
Equity Shares |
Rs.
10/- |
Rs.
0.500 Millions |
FINANCIAL DATA
[all
figures are in Rupees Millions]
|
Particulars |
31.03.2005 |
|
Sales Turnover |
50.000 |
LOCAL
AGENCY FURTHER INFORMATION
History
Subject
is incorporated in the year 1951 at Mumbai, Maharashtra.
Now it become change
its name and style under S. Zhaveri Pharmakem Private Limited, w.e.f 6th June, 2005, having New
Company Registration Number U51397MH2005PTC153790.
The concern is in
trade terms with:
Local:
- German Remedies Limited, M.Vasanji
Road, Andheri (East), Mumbai-93, India
- Novartis India Limited, Building
No.10, Ground Floor, Off Western Express Highway, Goregaon (East),
Mumbai-400 063, India
Foreign:
- Roehm GmbH, Germany, Chemische
Fabrik, Postfach 4242, Kirschenallee, D-64275, Darmstadt-1.
- J.Rettenmaier and Sohne, Germany,
D-7092, Ellwangam, Holzmuhle
Website
details attached herewith-
Profile
The
company is not just another corporate success story, it is the reflection of
the determination of the post independence generation of businessmen to succeed
against odds. It is the saga of a great visionary, Vinod B Seth, Chemistry
graduate of the Mumbai Royal Institute of Science.
The company started introducing to India pharmaceutical
& chemical industry reputed manufacturers from Germany, Italy, Japan, USA
and other countries. This was an important service and contribution to Indian
importers and industry since they were able to import from reputed markets from
other countries at more competitive price. Since then the company has never
looked back and has been growing continuously. It has maintained strong
customer relations and enjoys high reputation in the pharmaceutical and
chemical industry for Service, Integrity and Performance.
Export of Bulk
Drugs/Active Pharmaceutical Ingrediants produced by reputed Indian produer to
world wide.
Import of drug-intermediates / Fine chemicals / Excipients for Indian
formulation industries.
Contract Research Organization : Develop pharmaceutical dossier in Solid dosage
form for Indian and as well as international companies.
Activity:
- Contract Research
- Licensing & Business Development
- Sales & Distribution
Product
/ Technology type(s) covered:
- API / chemicals
- Generics
Therapeutic targets:
- AIDS
- Asthma
- Cancer
- Cardiovascular
- Central nervous system
- Cough / Cold
- Diabetes
- Gastrointestinal
- Infectious Diseases
- Mental Health
- Oncology
- Pain
- Respiratory Medicine
CMT REPORT [Corruption,
Money laundering & Terrorism]
The Public Notice
information has been collected from various sources including but not limited
to: The Courts, India Prisons Service, Interpol, etc.
1] INFORMATION ON DESIGNATED PARTY
No exist designating subject or any of
its beneficial owners, controlling shareholders or senior officers as terrorist
or terrorist organization or whom notice had been received that all financial
transactions involving their assets have been blocked or convicted, found
guilty or against whom a judgement or order had been entered in a proceedings
for violating money-laundering, anti-corruption or bribery or international economic
or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No
records exist to suggest that subject is or was the subject of any formal or
informal allegations, prosecutions or other official proceeding for making any
prohibited payments or other improper payments to government officials for
engaging in prohibited transactions or with designated parties.
3] Asset Declaration :
No records exist to suggest that the
property or assets of the subject are derived from criminal conduct or a
prohibited transaction.
4] Record on Financial Crime :
Charges or conviction registered
against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or investigation registered
against subject: None
6] Records on Int’l Anti-Money
Laundering Laws/Standards :
Charges or investigation registered
against subject: None
7] Criminal Records
No available information exist that suggest that subject or
any of its principals have been formally charged or convicted by a competent
governmental authority for any financial crime or under any formal
investigation by a competent government authority for any violation of
anti-corruption laws or international anti-money laundering laws or standard.
8] Affiliation with Government :
No record exists to suggest that any director or indirect
owners, controlling shareholders, director, officer or employee of the company
is a government official or a family member or close business associate of a
Government official.
9] Compensation Package :
Our market survey revealed that the amount of compensation
sought by the subject is fair and reasonable and comparable to compensation paid
to others for similar services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part
of its Due Diligence do provide comments on Corporate Governance to identify
management and governance. These factors often have been predictive and in some
cases have created vulnerabilities to credit deterioration.
Our Governance
Assessment focuses principally on the interactions between a company’s
management, its Board of Directors, Shareholders and other financial
stakeholders.
CONTRAVENTION
Subject is not known
to have contravened any existing local laws, regulations or policies that
prohibit, restrict or otherwise affect the terms and conditions that could be
included in the agreement with the subject.
FOREIGN
EXCHANGE RATES
|
Currency |
Unit
|
Indian
Rupees |
|
US Dollar |
1 |
Rs.44.30 |
|
UK Pound |
1 |
Rs.85.83 |
|
Euro |
1 |
Rs.57.92 |
SCORE
& RATING EXPLANATIONS
|
SCORE
FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
45 |
This score serves as a reference to
assess SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history (10%) Market
trend (10%) Operational
size (10%)
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound
financial base with the strongest capability for timely payment of interest
and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working
capital. No caution needed for credit transaction. It has above average
(strong) capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational base
are regarded healthy. General unfavourable factors will not cause fatal
effect. Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered
normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable
factors carry similar weight in credit consideration. Capability to overcome
financial difficulties seems comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent.
Repayment of interest and principal sums in default or expected to be in
default upon maturity |
Limited with full security |
|
<10 |
C |
Absolute credit risk exists.
Caution needed to be exercised |
Credit not recommended |